XML 32 R10.htm IDEA: XBRL DOCUMENT
v3.21.2

INVESTMENTS | 6 Months Ended
--- | ---
Jun. 30, 2021
Investments, Debt and Equity Securities [Abstract] |
INVESTMENTS | INVESTMENTS Debt Securities Investments in debt securities at the end of each period were as follows (in millions):
| June 30, 2021 |  | December 31, 2020
Held-to-maturity | Amortized Cost |  | Gross Unrealized Gains |  | Gross Unrealized Losses |  | Fair Value |  | Amortized Cost |  | Gross Unrealized Gains |  | Gross Unrealized Losses | Fair Value
Bank time deposits | $ | 35.0 |  |  | $ | — |  |  | $ | — |  |  | $ | 35.0 |  |  | $ | 50.0 |  |  | $ | — |  |  | $ | — |  |  | $ | 50.0 |
Available-for-sale |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Bank time deposits | $ | 3.0 |  |  | $ | — |  |  | $ | — |  |  | $ | 3.0 |  |  | $ | 24.1 |  |  | $ | — |  |  | $ | — |  |  | $ | 24.1 |
Commercial paper | 13.2 |  |  | — |  |  | — |  |  | 13.2 |  |  | — |  |  | — |  |  | — |  |  | — |
U.S. government and agency securities | 141.7 |  |  | 1.4 |  |  | (0.2) |  |  | 142.9 |  |  | 147.0 |  |  | 2.2 |  |  | — |  |  | 149.2 |
Asset-backed securities | 211.5 |  |  | 1.2 |  |  | (0.2) |  |  | 212.5 |  |  | 149.6 |  |  | 1.9 |  |  | — |  |  | 151.5 |
Corporate debt securities | 767.4 |  |  | 5.0 |  |  | (0.8) |  |  | 771.6 |  |  | 600.8 |  |  | 7.5 |  |  | — |  |  | 608.3 |
Municipal securities | 2.8 |  |  | — |  |  | — |  |  | 2.8 |  |  | 2.8 |  |  | — |  |  | — |  |  | 2.8 |
Total | $ | 1,139.6 |  |  | $ | 7.6 |  |  | $ | (1.2) |  |  | $ | 1,146.0 |  |  | $ | 924.3 |  |  | $ | 11.6 |  |  | $ | — |  |  | $ | 935.9 |
The cost and fair value of investments in debt securities, by contractual maturity, as of June 30, 2021, were as follows:
| Held-to-Maturity |  | Available-for-Sale
| Amortized Cost |  | Fair Value |  | Amortized Cost |  | Fair Value
| (in millions)
Due in 1 year or less | $ | 35.0 |  |  | $ | 35.0 |  |  | $ | 212.1 |  |  | $ | 213.4 |
Due after 1 year through 5 years | — |  |  | — |  |  | 663.6 |  |  | 667.1 |
Due after 5 years through 10 years | — |  |  | — |  |  | 10.2 |  |  | 10.4 |
Instruments not due at a single maturity date | — |  |  | — |  |  | 253.7 |  |  | 255.1 |
| $ | 35.0 |  |  | $ | 35.0 |  |  | $ | 1,139.6 |  |  | $ | 1,146.0 |
Actual maturities may differ from the contractual maturities due to call or prepayment rights. The following table presents gross unrealized losses and fair values for those investments that were in an unrealized loss position as of June 30, 2021, aggregated by investment category and the length of time that individual securities have been in a continuous loss position (in millions):
| June 30, 2021
| Less than 12 Months |  | 12 Months or Greater |  | Total
| Fair Value |  | Gross Unrealized Losses |  | Fair Value |  | Gross Unrealized Losses |  | Fair Value |  | Gross Unrealized Losses
U.S. government and agency securities | $ | 38.1 |  |  | $ | (0.2) |  |  | $ | — |  |  | $ | — |  |  | $ | 38.1 |  |  | $ | (0.2) |
Asset-backed securities | 83.4 |  |  | (0.2) |  |  | — |  |  | — |  |  | 83.4 |  |  | (0.2) |
Corporate debt securities | 260.5 |  |  | (0.8) |  |  | — |  |  | — |  |  | 260.5 |  |  | (0.8) |
| $ | 382.0 |  |  | $ | (1.2) |  |  | $ | — |  |  | $ | — |  |  | $ | 382.0 |  |  | $ | (1.2) |
There were no investments that were in an unrealized loss position as of December 31, 2020. Investments in Unconsolidated Entities The Company has a number of equity investments in privately and publicly held companies. Investments in these unconsolidated entities are recorded in "Long-term Investments" on the consolidated condensed balance sheets, and are as follows:
| June 30, 2021 |  | December 31, 2020
| (in millions)
Equity method investments |  |  |
Carrying value of equity method investments | $ | 8.0 |  |  | $ | 5.7 |
Equity securities |  |  |
Carrying value of non-marketable equity securities | 73.6 |  |  | 29.4 |
Total investments in unconsolidated entities | $ | 81.6 |  |  | $ | 35.1 |
Non-marketable equity securities consist of investments in privately held companies without readily determinable fair values, and are reported at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar investment of the same issuer. The Company recorded an upward adjustment of $2.6 million during the six months ended June 30, 2021 based on observable price changes. As of June 30, 2021, the Company had recorded accumulated upward adjustments of $6.4 million based on observable price changes, and accumulated downward adjustments of $2.6 million due to impairments and observable price changes. In April 2021, the Company recorded $35.9 million related to its investment in a privately-held medical device company (the "investee"), including an initial cash investment in the investee's preferred equity securities and other consideration. Edwards also paid $5.7 million, included in "Other Assets," for an exclusive contingent option to acquire the investee. Edwards may be required to invest up to an additional $9.9 million in the investee's preferred equity securities and up to an additional $21.8 million for the option to acquire the investee, depending on the achievement of certain milestones. Edwards also agreed to loan the investee up to $45 million under a secured promissory note. As of June 30, 2021, there had been no borrowings under this secured promissory note. The investee is a variable interest entity ("VIE"); however, Edwards has determined that it is not the primary beneficiary of the VIE since Edwards does not have the power to direct the activities of the investee that most significantly impact the investee's economic performance. Edwards accounts for this investment as a non-marketable equity security under the measurement alternative. During the three and six months ended June 30, 2021, the gross realized gains or losses from sales of available-for-sale investments were not material.

X
- References No definition available. + Details
Name: | us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for investments in certain debt and equity securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 320 -URI http://asc.fasb.org/subtopic&trid=2209399 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 946 -SubTopic 320 -URI http://asc.fasb.org/subtopic&trid=2324412 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 320 -URI http://asc.fasb.org/topic&trid=2196928 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 940 -SubTopic 320 -URI http://asc.fasb.org/subtopic&trid=2176304 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher SEC -Name Regulation S-K (SK) -Number 229 -Section 1403 -Paragraph (b) + Details
Name: | us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration